Outlander,
Definitely not laughing here. I have always thought about the potential treatment of Autism Spectrum disorders in the broader context off the back of positive results and FDA approvals for the 4 indications currently in P2 trials. Retts falls under one of the five major types of autism ( Asperger's syndrome, Rett syndrome, childhood disintegrative disorder, Kanner's syndrome, and pervasive developmental disorder). Considering Neuren believe NNZ-2591 has superior MoA I suspect you'll need a bigger calculator if all goes as well as trofinetide.
The mind boggles when thinking about the potential of this little engine that could.
Share Price, page-3321
-
- There are more pages in this discussion • 8,122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.21 |
Change
-0.270(1.74%) |
Mkt cap ! $1.944B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $8.268M | 543.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.24 | 220 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |